Precigen (PGEN) Financials

$1.32 -0.09 (-6.38%)

Closing price 04:00 PM Eastern

Extended Trading

$1.34 +0.01 (+1.14%)

As of 07:52 PM Eastern

Annual Income Statements for Precigen

This table shows Precigen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-126	-96	28
Consolidated Net Income / (Loss)	-126	-96	35
Net Income / (Loss) Continuing Operations	-126	-96	-80
Total Pre-Tax Income	-128	-96	-80
Total Operating Income	-135	-99	-76
Total Gross Profit	-4.27	0.11	21
Total Revenue	0.00	6.23	27
Total Cost of Revenue	4.27	6.12	6.34
Operating Cost of Revenue	4.27	6.12	6.34
Total Operating Expenses	142	99	96
Selling, General & Admin Expense	41	40	48
Research & Development Expense	53	49	47
Impairment Charge	48	10	1.12
Total Other Income / (Expense), net	7.00	3.86	2.53
Interest & Investment Income	1.42	3.24	1.00
Other Income / (Expense), net	14	0.63	1.54
Income Tax Expense	-3.59	-	-0.19
Basic Earnings per Share	($0.47)	($0.39)	$0.14
Weighted Average Basic Shares Outstanding	267.73M	244.54M	200.36M
Diluted Earnings per Share	($0.47)	($0.39)	$0.14
Weighted Average Diluted Shares Outstanding	267.73M	244.54M	200.36M
Weighted Average Basic & Diluted Shares Outstanding	294.04M	248.92M	252.19M

This table shows Precigen's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-21	-24	-58	-24	-33	-20	-20	-23	-22	87
Consolidated Net Income / (Loss)	-20	-24	-59	-24	-33	-20	-20	-23	-15	87
Net Income / (Loss) Continuing Operations	-21	-24	-58	-24	-34	-20	-20	-23	-22	-7.64
Total Pre-Tax Income	-20	-24	-60	-24	-33	-20	-20	-23	-22	-7.69
Total Operating Income	-29	-21	-61	-24	-34	-21	-21	-23	-22	-7.61
Total Gross Profit	-4.62	-0.06	0.42	-0.01	-0.13	-0.16	0.07	0.32	0.51	15
Total Revenue	-3.45	0.95	1.43	1.07	1.23	1.38	1.77	1.85	1.76	17
Total Cost of Revenue	1.17	1.01	1.01	1.08	1.36	1.54	1.70	1.53	1.26	1.58
Operating Cost of Revenue	1.17	1.01	1.01	1.08	1.36	1.54	1.70	1.53	1.26	1.58
Total Operating Expenses	34	21	62	24	34	21	21	24	22	23
Selling, General & Admin Expense	11	9.84	10	10	10	9.20	9.32	12	12	10
Research & Development Expense	12	11	16	14	13	12	12	12	11	13
Total Other Income / (Expense), net	8.70	-2.70	0.36	0.64	1.17	1.14	0.87	0.69	6.40	-0.08
Interest & Investment Income	0.21	0.28	0.32	0.61	0.92	0.86	0.83	0.63	0.00	0.92
Other Income / (Expense), net	17	-2.99	0.04	0.04	-0.08	0.28	0.04	0.38	0.26	1.04
Income Tax Expense	-0.16	0.01	-3.38	-0.06	-	-0.01	-0.07	-0.11	0.01	-0.05
Basic Earnings per Share	($0.05)	($0.09)	($0.23)	($0.10)	($0.13)	($0.08)	($0.08)	($0.10)	($0.11)	$0.44
Weighted Average Basic Shares Outstanding	267.73M	275.88M	252.37M	249.22M	244.54M	248.52M	248.00M	229.77M	200.36M	200.67M
Diluted Earnings per Share	($0.05)	($0.09)	($0.23)	($0.10)	($0.13)	($0.08)	($0.08)	($0.10)	($0.11)	$0.44
Weighted Average Diluted Shares Outstanding	267.73M	275.88M	252.37M	249.22M	244.54M	248.52M	248.00M	229.77M	200.36M	200.67M
Weighted Average Basic & Diluted Shares Outstanding	294.04M	292.87M	252.76M	252.42M	248.92M	248.92M	255.48M	255.48M	252.19M	208.15M

This table details how cash moves in and out of Precigen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	22	-41	5.25
Net Cash From Operating Activities	-68	-67	-65
Net Cash From Continuing Operating Activities	-68	-67	-65
Net Income / (Loss) Continuing Operations	-126	-96	28
Consolidated Net Income / (Loss)	-126	-96	28
Depreciation Expense	4.53	6.67	11
Amortization Expense	-0.88	-1.75	1.87
Non-Cash Adjustments To Reconcile Net Income	52	7.46	-70
Changes in Operating Assets and Liabilities, net	2.73	17	-36
Net Cash From Investing Activities	-21	-3.09	226
Net Cash From Continuing Investing Activities	-21	-3.09	226
Purchase of Property, Plant & Equipment	-8.58	-1.54	-4.92
Purchase of Investments	-187	-185	0.00
Sale of Property, Plant & Equipment	0.06	0.10	0.59
Divestitures	0.00	0.00	162
Sale and/or Maturity of Investments	175	183	68
Net Cash From Financing Activities	111	30	-155
Net Cash From Continuing Financing Activities	111	30	-155
Repayment of Debt	0.00	-43	-155
Issuance of Preferred Equity	79	0.00	0.00
Issuance of Common Equity	31	73	0.00
Other Financing Activities, net	0.35	0.00	0.00
Effect of Exchange Rate Changes	-0.03	-0.32	-0.83
Cash Interest Paid	0.01	1.17	8.54
Cash Income Taxes Paid	0.00	0.02	0.00

This table details how cash moves in and out of Precigen's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	4.79	15	-8.14	9.90	-2.49	-6.62	-6.99	-25	-43	42
Net Cash From Operating Activities	-8.24	-23	-23	-14	-16	-17	-16	-18	-15	-24
Net Cash From Continuing Operating Activities	-8.24	-23	-23	-14	-16	-17	-16	-18	-15	-24
Net Income / (Loss) Continuing Operations	-20	-24	-59	-24	-33	-20	-20	-23	-22	87
Consolidated Net Income / (Loss)	-20	-24	-59	-24	-33	-20	-20	-23	-22	87
Depreciation Expense	0.66	0.67	1.60	1.60	1.61	1.65	1.69	1.71	1.72	2.53
Amortization Expense	-0.15	-0.16	-0.17	-0.40	-0.52	-0.57	-0.49	-0.17	0.27	0.54
Non-Cash Adjustments To Reconcile Net Income	8.94	5.00	35	3.08	0.09	1.61	2.20	3.57	16	-94
Changes in Operating Assets and Liabilities, net	2.04	-4.27	-0.41	5.37	16	0.10	1.16	-0.77	-11	-20
Net Cash From Investing Activities	-65	5.65	15	24	13	11	24	-50	11	182
Net Cash From Continuing Investing Activities	-65	5.65	15	24	13	11	24	-50	11	182
Purchase of Property, Plant & Equipment	-1.03	-0.88	-2.32	-4.35	-1.05	-0.24	-0.10	-0.15	-0.05	-1.57
Purchase of Investments	-112	-23	-34	-17	-31	-25	-20	-108	-	-
Sale and/or Maturity of Investments	48	30	52	46	46	36	44	58	11	21
Net Cash From Financing Activities	78	32	0.05	0.00	-	-	-15	44	-39	-116
Net Cash From Continuing Financing Activities	78	32	0.05	0.00	-	-	-15	44	-39	-116
Issuance of Common Equity	-0.60	32	-	0.00	-	-	-0.69	74	-	-
Effect of Exchange Rate Changes	-0.00	0.07	-0.04	-0.06	-0.01	-0.13	-0.14	-0.03	-0.02	-0.33

This table presents Precigen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	145	151	216
Total Current Assets	102	69	118
Cash & Equivalents	30	7.58	4.86
Short-Term Investments	68	55	51
Accounts Receivable	1.16	1.58	14
Prepaid Expenses	3.34	4.33	5.07
Plant, Property, & Equipment, net	14	7.11	7.33
Total Noncurrent Assets	29	75	90
Goodwill	19	27	37
Intangible Assets	4.46	41	44
Other Noncurrent Operating Assets	5.43	7.86	9.11
Total Liabilities & Shareholders' Equity	145	151	216
Total Liabilities	79	33	90
Total Current Liabilities	22	23	79
Accounts Payable	3.53	1.73	4.07
Accrued Expenses	4.81	6.22	5.00
Current Deferred Revenue	0.59	0.51	0.03
Current Employee Benefit Liabilities	8.42	8.25	6.38
Other Current Liabilities	4.17	6.28	20
Total Noncurrent Liabilities	57	9.56	11
Noncurrent Deferred Revenue	1.93	1.82	1.82
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	1.85	2.26
Other Noncurrent Operating Liabilities	55	5.90	6.99
Commitments & Contingencies	0.00	0.00	0.00
Redeemable Noncontrolling Interest	28	0.00	-
Total Equity & Noncontrolling Interests	39	118	126
Total Preferred & Common Equity	39	118	126
Total Common Equity	39	118	126
Common Stock	2,129	2,085	1,998
Retained Earnings	-2,091	-1,964	-1,869
Accumulated Other Comprehensive Income / (Loss)	0.01	-1.95	-3.49

This table presents Precigen's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	83	73	135	191	208	242	259
Total Current Assets	35	24	50	93	106	138	163
Cash & Equivalents	25	9.35	17	10	17	9.74	9.07
Short-Term Investments	3.91	10	27	64	72	94	62
Accounts Receivable	0.73	1.02	1.16	14	14	16	2.45
Prepaid Expenses	5.15	3.16	3.63	5.13	2.79	4.33	6.36
Plant, Property, & Equipment, net	14	13	13	7.12	6.57	6.91	7.61
Total Noncurrent Assets	35	36	73	91	95	97	89
Goodwill	25	25	27	37	37	37	37
Intangible Assets	4.77	5.09	39	40	43	44	42
Other Noncurrent Operating Assets	5.73	5.99	7.41	7.99	8.57	8.62	9.70
Total Liabilities & Shareholders' Equity	83	73	135	191	208	242	259
Total Liabilities	28	30	38	43	41	57	117
Total Current Liabilities	21	23	29	33	31	47	105
Accounts Payable	4.32	4.85	4.72	2.35	2.51	3.81	4.20
Accrued Expenses	5.68	6.64	7.30	4.12	3.26	23	12
Current Deferred Revenue	0.41	0.38	0.41	0.51	0.02	0.02	0.08
Current Employee Benefit Liabilities	6.61	6.68	9.96	6.62	4.82	4.96	5.79
Other Current Liabilities	4.20	4.48	6.39	19	20	1.24	1.04
Total Noncurrent Liabilities	6.88	6.97	9.05	10	11	11	12
Noncurrent Deferred Revenue	2.03	1.82	1.89	1.82	1.82	1.82	1.82
Noncurrent Deferred & Payable Income Tax Liabilities	0.09	0.08	1.78	2.13	2.18	2.24	2.09
Other Noncurrent Operating Liabilities	4.76	5.07	5.39	6.19	6.55	6.62	7.94
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	55	43	97	148	166	184	143
Total Preferred & Common Equity	55	43	97	148	166	184	143
Total Common Equity	55	43	97	148	166	184	143
Common Stock	2,126	2,093	2,088	2,083	2,080	2,078	1,996
Retained Earnings	-2,071	-2,047	-1,988	-1,931	-1,912	-1,891	-1,846
Accumulated Other Comprehensive Income / (Loss)	0.01	-2.91	-2.80	-3.56	-2.52	-2.70	-7.18

This table displays calculated financial ratios and metrics derived from Precigen's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	-100.00%	-76.87%	88.61%
EBITDA Growth	-25.09%	-52.35%	6.25%
EBIT Growth	-22.55%	-33.02%	19.69%
NOPAT Growth	-35.96%	-31.15%	17.64%
Net Income Growth	-31.63%	-373.30%	138.07%
EPS Growth	-20.51%	-378.57%	129.79%
Operating Cash Flow Growth	-1.86%	-2.90%	-16.63%
Free Cash Flow Firm Growth	86.00%	11.48%	-451.38%
Invested Capital Growth	-156.03%	-20.72%	14.88%
Revenue Q/Q Growth	-100.00%	-7.91%	165.10%
EBITDA Q/Q Growth	15.64%	-16.41%	-6.84%
EBIT Q/Q Growth	15.59%	-14.27%	1.09%
NOPAT Q/Q Growth	3.75%	-13.72%	5.86%
Net Income Q/Q Growth	9.55%	-22.56%	37.83%
EPS Q/Q Growth	14.55%	-5.41%	16.67%
Operating Cash Flow Q/Q Growth	9.94%	-0.56%	-1.26%
Free Cash Flow Firm Q/Q Growth	86.33%	6.75%	-2,212.36%
Invested Capital Q/Q Growth	-216.58%	-18.95%	-0.91%
Profitability Metrics	-	-	-
Gross Margin	0.00%	1.70%	76.44%
EBITDA Margin	0.00%	-1,506.30%	-228.73%
Operating Margin	0.00%	-1,595.39%	-281.42%
EBIT Margin	0.00%	-1,585.32%	-275.70%
Profit (Net Income) Margin	0.00%	-1,540.63%	130.41%
Tax Burden Percent	98.60%	99.52%	-43.88%
Interest Burden Percent	105.86%	97.65%	107.79%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-110.50%	-80.75%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-66.12%	-252.95%
Return on Net Nonoperating Assets (RNNOA)	0.00%	32.13%	110.80%
Return on Equity (ROE)	-136.30%	-78.37%	30.04%
Cash Return on Invested Capital (CROIC)	0.00%	-87.38%	-94.61%
Operating Return on Assets (OROA)	0.00%	-53.78%	-25.77%
Return on Assets (ROA)	0.00%	-52.26%	12.19%
Return on Common Equity (ROCE)	-115.54%	-78.37%	30.04%
Return on Equity Simple (ROE_SIMPLE)	-327.77%	-80.93%	27.79%
Net Operating Profit after Tax (NOPAT)	-95	-70	-53
NOPAT Margin	0.00%	-1,116.77%	-196.99%
Net Nonoperating Expense Percent (NNEP)	-39.45%	-44.37%	172.20%
Return On Investment Capital (ROIC_SIMPLE)	-245.42%	-58.67%	-31.28%
Cost of Revenue to Revenue	0.00%	98.30%	23.56%
SG&A Expenses to Revenue	0.00%	649.24%	178.40%
R&D to Revenue	0.00%	780.95%	175.29%
Operating Expenses to Revenue	0.00%	1,597.09%	357.86%
Earnings before Interest and Taxes (EBIT)	-121	-99	-74
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-117	-94	-62
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	8.52	2.81	2.51
Price to Tangible Book Value (P/TBV)	21.99	6.52	7.05
Price to Revenue (P/Rev)	0.00	53.58	11.76
Price to Earnings (P/E)	0.00	0.00	11.17
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	8.95%
Enterprise Value to Invested Capital (EV/IC)	0.00	4.86	3.71
Enterprise Value to Revenue (EV/Rev)	0.00	43.49	9.67
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.00	0.00	0.34
Long-Term Debt to Equity	0.00	0.00	0.00
Financial Leverage	-0.87	-0.49	-0.44
Leverage Ratio	1.60	1.50	2.47
Compound Leverage Factor	1.69	1.46	2.66
Debt to Total Capital	0.00%	0.00%	25.50%
Short-Term Debt to Total Capital	0.00%	0.00%	25.50%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	42.29%	0.00%	0.00%
Common Equity to Total Capital	57.71%	100.00%	74.50%
Debt to EBITDA	0.00	0.00	-0.70
Net Debt to EBITDA	0.00	0.00	0.91
Long-Term Debt to EBITDA	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	-0.82
Net Debt to NOPAT	0.00	0.00	1.06
Long-Term Debt to NOPAT	0.00	0.00	0.00
Altman Z-Score	-19.72	-13.81	-10.79
Noncontrolling Interest Sharing Ratio	15.23%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	4.76	2.99	1.50
Quick Ratio	4.60	2.80	0.89
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-7.70	-55	-62
Operating Cash Flow to CapEx	-799.78%	-4,654.38%	-1,502.19%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.00	0.03	0.09
Accounts Receivable Turnover	0.00	0.81	3.41
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.86	3.38
Accounts Payable Turnover	1.62	2.11	1.75
Days Sales Outstanding (DSO)	0.00	450.87	107.05
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	224.84	172.81	208.84
Cash Conversion Cycle (CCC)	0.00	278.06	-101.79
Capital & Investment Metrics	-	-	-
Invested Capital	-31	56	70
Invested Capital Turnover	0.00	0.10	0.41
Increase / (Decrease) in Invested Capital	-87	-15	9.09
Enterprise Value (EV)	258	271	260
Market Capitalization	328	334	316
Book Value per Share	$0.13	$0.48	$0.61
Tangible Book Value per Share	$0.05	$0.21	$0.22
Total Capital	67	118	169
Total Debt	0.00	0.00	43
Total Long-Term Debt	0.00	0.00	0.00
Net Debt	-98	-63	-56
Capital Expenditures (CapEx)	8.52	1.44	4.33
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-17	-17	-17
Debt-free Net Working Capital (DFNWC)	81	46	83
Net Working Capital (NWC)	81	46	40
Net Nonoperating Expense (NNE)	32	26	-88
Net Nonoperating Obligations (NNO)	-98	-63	-56
Total Depreciation and Amortization (D&A)	3.64	4.92	13
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-274.46%	-61.53%
Debt-free Net Working Capital to Revenue	0.00%	735.26%	307.45%
Net Working Capital to Revenue	0.00%	735.26%	146.84%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.47)	($0.39)	$0.14
Adjusted Weighted Average Basic Shares Outstanding	267.73M	244.54M	200.36M
Adjusted Diluted Earnings per Share	($0.47)	($0.39)	$0.14
Adjusted Weighted Average Diluted Shares Outstanding	267.73M	244.54M	200.36M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	294.04M	248.92M	252.19M
Normalized Net Operating Profit after Tax (NOPAT)	-61	-62	-52
Normalized NOPAT Margin	0.00%	-999.94%	-194.08%
Pre Tax Income Margin	0.00%	-1,547.98%	-297.17%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Precigen's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-381.11%	-30.89%	-18.85%	-42.46%	-30.35%	-91.75%	-39.30%	-66.42%	102.65%	401.71%
EBITDA Growth	66.38%	-21.23%	-198.74%	-7.51%	-67.64%	-457.33%	2.48%	-19.00%	-25.26%	76.36%
EBIT Growth	65.97%	-17.38%	-188.47%	-5.52%	-57.22%	-214.11%	12.63%	-5.21%	3.66%	69.64%
NOPAT Growth	15.58%	-1.55%	-188.07%	-3.97%	-54.97%	-174.98%	12.59%	-5.98%	17.79%	64.64%
Net Income Growth	40.32%	-21.13%	-189.34%	-4.42%	-114.62%	-122.65%	-15.22%	-18.09%	38.48%	393.57%
EPS Growth	61.54%	-12.50%	-187.50%	0.00%	-18.18%	-118.18%	11.11%	0.00%	15.38%	393.33%
Operating Cash Flow Growth	47.72%	-33.66%	-46.54%	23.37%	-2.40%	28.58%	-123.56%	2.10%	-5.53%	-39.90%
Free Cash Flow Firm Growth	834.85%	316.59%	113.78%	-92.64%	62.64%	-123.14%	-148.70%	615.64%	-138.36%	1,027.58%
Invested Capital Growth	-156.03%	-61.04%	-66.55%	-28.02%	-20.72%	-3.08%	32.54%	-45.51%	14.88%	-45.55%
Revenue Q/Q Growth	-462.22%	-33.54%	34.65%	-13.27%	-10.95%	-21.96%	-4.54%	4.99%	-89.46%	474.44%
EBITDA Q/Q Growth	53.60%	60.03%	-156.20%	29.25%	-67.31%	1.49%	7.80%	-10.32%	-456.22%	82.76%
EBIT Q/Q Growth	52.48%	60.12%	-149.45%	28.01%	-63.90%	1.99%	8.75%	-7.26%	-227.46%	72.74%
NOPAT Q/Q Growth	-34.12%	65.05%	-149.25%	27.73%	-61.33%	0.87%	10.04%	-7.71%	-186.28%	68.49%
Net Income Q/Q Growth	17.73%	59.22%	-147.67%	28.19%	-66.99%	2.58%	10.62%	-47.60%	-117.63%	595.49%
EPS Q/Q Growth	44.44%	60.87%	-130.00%	23.08%	-62.50%	0.00%	20.00%	9.09%	-125.00%	588.89%
Operating Cash Flow Q/Q Growth	63.74%	1.62%	-64.00%	10.63%	7.30%	-7.86%	14.25%	-19.43%	35.35%	-237.63%
Free Cash Flow Firm Q/Q Growth	147.42%	510.52%	36.07%	135.75%	27.08%	61.17%	-172.67%	281.56%	-145.16%	-18.27%
Invested Capital Q/Q Growth	-216.58%	13.16%	-54.78%	-6.08%	-18.95%	-2.83%	-2.69%	3.44%	-0.91%	32.88%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	-5.88%	29.29%	-0.94%	-10.59%	-11.46%	3.96%	17.50%	28.70%	90.57%
EBITDA Margin	0.00%	-2,490.56%	-4,140.52%	-2,176.06%	-2,667.51%	-1,419.80%	-1,124.79%	-1,164.56%	-1,108.34%	-21.01%
Operating Margin	0.00%	-2,231.06%	-4,242.75%	-2,292.02%	-2,750.65%	-1,518.27%	-1,195.25%	-1,268.40%	-1,236.36%	-45.53%
EBIT Margin	0.00%	-2,544.28%	-4,239.75%	-2,288.54%	-2,757.00%	-1,497.90%	-1,192.76%	-1,247.87%	-1,221.44%	-39.33%
Profit (Net Income) Margin	0.00%	-2,516.05%	-4,099.86%	-2,228.92%	-2,691.86%	-1,435.46%	-1,149.92%	-1,228.20%	-873.62%	522.54%
Tax Burden Percent	99.56%	100.05%	97.21%	99.88%	99.01%	99.97%	99.68%	99.76%	69.48%	-1,135.68%
Interest Burden Percent	171.97%	98.84%	99.48%	97.51%	98.62%	95.86%	96.72%	98.66%	102.94%	117.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-153.23%	-321.68%	-139.78%	-190.51%	-103.02%	-298.39%	-200.54%	-354.78%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-136.34%	-293.52%	-131.27%	-174.68%	-96.20%	-287.08%	-176.37%	-354.49%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	72.28%	161.35%	72.97%	84.88%	49.96%	126.69%	35.63%	155.27%	0.00%
Return on Equity (ROE)	-136.30%	-80.95%	-160.33%	-66.81%	-105.63%	-53.05%	-171.70%	-164.91%	-199.50%	18.60%
Cash Return on Invested Capital (CROIC)	0.00%	-118.03%	-108.10%	-79.82%	-87.38%	-84.53%	-111.58%	6.52%	-94.61%	2.93%
Operating Return on Assets (OROA)	0.00%	-86.86%	-154.25%	-66.14%	-93.52%	-45.01%	-99.72%	-100.53%	-114.16%	0.00%
Return on Assets (ROA)	0.00%	-85.90%	-149.16%	-64.42%	-91.31%	-43.13%	-96.14%	-98.95%	-81.65%	0.00%
Return on Common Equity (ROCE)	-115.54%	-80.95%	-160.33%	-66.81%	-105.63%	-53.05%	-171.70%	-164.91%	-199.50%	18.60%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-252.03%	-313.60%	-99.89%	0.00%	-52.99%	17.40%	17.17%	0.00%	17.86%
Net Operating Profit after Tax (NOPAT)	-20	-15	-43	-17	-24	-15	-15	-16	-15	-5.33
NOPAT Margin	0.00%	-1,561.74%	-2,969.92%	-1,604.41%	-1,925.46%	-1,062.79%	-836.67%	-887.88%	-865.45%	-31.87%
Net Nonoperating Expense Percent (NNEP)	0.29%	-16.90%	-28.16%	-8.51%	-15.83%	-6.82%	-11.31%	-24.17%	-0.28%	254.46%
Return On Investment Capital (ROIC_SIMPLE)	-51.83%	-26.88%	-98.65%	-17.61%	-19.95%	-9.92%	-8.89%	-8.30%	-9.00%	-2.37%
Cost of Revenue to Revenue	0.00%	105.88%	70.71%	100.94%	110.59%	111.46%	96.04%	82.50%	71.30%	9.43%
SG&A Expenses to Revenue	0.00%	1,032.11%	718.69%	953.15%	835.83%	666.86%	527.22%	628.80%	652.86%	60.62%
R&D to Revenue	0.00%	1,193.07%	1,094.35%	1,337.93%	1,058.14%	839.96%	671.99%	657.10%	612.20%	75.48%
Operating Expenses to Revenue	0.00%	2,225.18%	4,335.70%	2,291.08%	2,740.07%	1,506.82%	1,199.21%	1,285.90%	1,265.06%	136.10%
Earnings before Interest and Taxes (EBIT)	-12	-24	-61	-24	-34	-21	-21	-23	-22	-6.58
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-11	-24	-59	-23	-33	-20	-20	-22	-20	-3.51
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.52	4.32	9.24	3.72	2.81	2.46	1.77	1.45	2.51	3.10
Price to Tangible Book Value (P/TBV)	21.99	9.32	30.30	11.37	6.52	5.16	3.39	2.59	7.05	6.96
Price to Revenue (P/Rev)	0.00	51.15	78.11	66.36	53.58	53.67	13.29	11.50	11.76	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	13.26	10.76	11.17	19.37
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	7.54%	9.29%	8.95%	5.16%
Enterprise Value to Invested Capital (EV/IC)	0.00	7.88	16.05	6.05	4.86	4.13	2.81	2.15	3.71	5.22
Enterprise Value to Revenue (EV/Rev)	0.00	45.03	74.28	58.13	43.49	41.98	8.97	6.70	9.67	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	23.22	0.00	125.71
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.08	0.34	0.58
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.87	-0.53	-0.55	-0.56	-0.49	-0.52	-0.44	-0.20	-0.44	-0.27
Leverage Ratio	1.60	1.35	1.34	1.34	1.50	1.55	2.38	2.24	2.47	2.32
Compound Leverage Factor	2.75	1.33	1.33	1.31	1.48	1.49	2.31	2.21	2.54	2.72
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.98%	25.50%	36.54%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.98%	25.50%	36.54%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	42.29%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	57.71%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	93.02%	74.50%	63.46%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.21	-0.70	-1.42
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.72	0.91	1.24
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.26	-0.82	-1.46
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.07	1.06	1.27
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	-17.24	-30.33	-33.85	-15.29	-12.39	-9.06	-8.43	-7.94	-9.98	-7.68
Noncontrolling Interest Sharing Ratio	15.23%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.76	1.63	1.03	1.72	2.99	2.83	3.43	2.95	1.50	1.55
Quick Ratio	4.60	1.38	0.89	1.60	2.80	2.67	3.34	2.56	0.89	0.70
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	67	27	4.43	3.25	-9.10	-12	-32	44	-24	54
Operating Cash Flow to CapEx	-801.85%	-2,755.52%	-994.71%	-324.06%	-1,564.09%	-7,206.78%	-39,420.00%	-11,940.26%	-29,049.06%	-1,679.34%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	1,626.50	0.00	0.00	0.00	136.45	0.00	26.48
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	-7,045.00	0.00	0.00	0.00	-56.75	0.00	-11.70
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	-9,219.00	0.00	0.00	0.00	-57.23	0.00	-12.39
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.03	0.04	0.03	0.03	0.03	0.08	0.08	0.09	0.00
Accounts Receivable Turnover	0.00	0.63	0.66	0.65	0.81	0.82	2.72	1.15	3.41	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.45	0.51	0.56	0.86	0.92	3.09	1.15	3.38	0.00
Accounts Payable Turnover	1.62	1.34	1.36	1.33	2.11	1.84	2.31	1.50	1.75	0.00
Days Sales Outstanding (DSO)	0.00	578.46	551.22	559.81	450.87	447.04	134.40	317.07	107.05	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	224.84	273.22	269.36	274.54	172.81	198.69	157.74	243.94	208.84	0.00
Cash Conversion Cycle (CCC)	0.00	305.25	281.86	285.28	278.06	248.35	-23.34	73.12	-101.79	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-31	27	24	52	56	69	71	73	70	71
Invested Capital Turnover	0.00	0.10	0.11	0.09	0.10	0.10	0.36	0.23	0.41	0.00
Increase / (Decrease) in Invested Capital	-87	-42	-47	-20	-15	-2.18	17	-61	9.09	-59
Enterprise Value (EV)	258	211	379	316	271	284	198	156	260	370
Market Capitalization	328	239	399	361	334	363	294	267	316	441
Book Value per Share	$0.13	$0.22	$0.17	$0.39	$0.48	$0.58	$0.65	$0.73	$0.61	$0.68
Tangible Book Value per Share	$0.05	$0.10	$0.05	$0.13	$0.21	$0.28	$0.34	$0.41	$0.22	$0.30
Total Capital	67	55	43	97	118	148	166	198	169	225
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	14	43	82
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-98	-29	-20	-45	-63	-79	-96	-112	-56	-72
Capital Expenditures (CapEx)	1.03	0.83	2.32	4.35	1.01	0.24	0.04	0.15	0.05	1.42
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-17	-15	-19	-24	-17	-14	-14	-13	-17	-14
Debt-free Net Working Capital (DFNWC)	81	13	0.69	21	46	60	75	105	83	140
Net Working Capital (NWC)	81	13	0.69	21	46	60	75	91	40	58
Net Nonoperating Expense (NNE)	-0.23	9.09	16	6.65	9.41	5.14	5.54	6.30	0.14	-93
Net Nonoperating Obligations (NNO)	-98	-29	-20	-45	-63	-79	-96	-112	-56	-72
Total Depreciation and Amortization (D&A)	0.51	0.51	1.42	1.20	1.10	1.08	1.20	1.54	1.99	3.06
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-327.65%	-369.06%	-441.00%	-274.46%	-201.80%	-61.42%	-56.19%	-61.53%	0.00%
Debt-free Net Working Capital to Revenue	0.00%	284.12%	13.55%	381.91%	735.26%	889.25%	338.68%	450.94%	307.45%	0.00%
Net Working Capital to Revenue	0.00%	284.12%	13.55%	381.91%	735.26%	889.25%	338.68%	391.49%	146.84%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.05)	($0.09)	($0.23)	($0.10)	($0.13)	($0.08)	($0.08)	($0.10)	($0.11)	$0.44
Adjusted Weighted Average Basic Shares Outstanding	267.73M	275.88M	252.37M	249.22M	244.54M	248.52M	248.00M	229.77M	200.36M	200.67M
Adjusted Diluted Earnings per Share	($0.05)	($0.09)	($0.23)	($0.10)	($0.13)	($0.08)	($0.08)	($0.10)	($0.11)	$0.44
Adjusted Weighted Average Diluted Shares Outstanding	267.73M	275.88M	252.37M	249.22M	244.54M	248.52M	248.00M	229.77M	200.36M	200.67M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	294.04M	292.87M	252.76M	252.42M	248.92M	248.92M	255.48M	255.48M	252.19M	208.15M
Normalized Net Operating Profit after Tax (NOPAT)	-20	-15	-17	-17	-24	-15	-15	-16	-15	-5.33
Normalized NOPAT Margin	0.00%	-1,561.74%	-1,204.06%	-1,604.41%	-1,925.46%	-1,062.79%	-836.67%	-887.88%	-865.45%	-31.87%
Pre Tax Income Margin	0.00%	-2,514.80%	-4,217.64%	-2,231.64%	-2,718.89%	-1,435.90%	-1,153.59%	-1,231.17%	-1,257.40%	-46.01%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	-12,186.50	0.00	0.00	0.00	-71.29	0.00	-3.23
NOPAT to Interest Expense	0.00	0.00	0.00	-8,543.50	0.00	0.00	0.00	-50.72	0.00	-2.62
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-14,360.50	0.00	0.00	0.00	-71.77	0.00	-3.93
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-10,717.50	0.00	0.00	0.00	-51.20	0.00	-3.31
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Precigen's Financials

When does Precigen's financial year end?

According to the most recent income statement we have on file, Precigen's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Precigen's net income changed over the last 2 years?

Precigen's net income appears to be on an upward trend, with a most recent value of -$126.24 million in 2024, falling from $35.09 million in 2022. The previous period was -$95.90 million in 2023. Find out what analysts predict for Precigen in the coming months.

What is Precigen's operating income?

Precigen's total operating income in 2024 was -$135.03 million, based on the following breakdown:

Total Gross Profit: -$4.27 million
Total Operating Expenses: $142.10 million

How has Precigen revenue changed over the last 2 years?

Over the last 2 years, Precigen's total revenue changed from $26.91 million in 2022 to $0.00 in 2024, a change of -100.0%.

How much debt does Precigen have?

Precigen's total liabilities were at $78.54 million at the end of 2024, a 141.3% increase from 2023, and a 12.5% decrease since 2022.

How much cash does Precigen have?

In the past 2 years, Precigen's cash and equivalents has ranged from $4.86 million in 2022 to $29.52 million in 2024, and is currently $29.52 million as of their latest financial filing in 2024.

How has Precigen's book value per share changed over the last 2 years?

Over the last 2 years, Precigen's book value per share changed from 0.61 in 2022 to 0.13 in 2024, a change of -78.3%.

Related Companies

This page (NASDAQ:PGEN) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Precigen (PGEN) Financials

Frequently Asked Questions About Precigen's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Precigen (PGEN) Financials

Annual Income Statements for Precigen

Quarterly Income Statements for Precigen

Annual Cash Flow Statements for Precigen

Quarterly Cash Flow Statements for Precigen

Annual Balance Sheets for Precigen

Quarterly Balance Sheets for Precigen

Annual Metrics And Ratios for Precigen

Quarterly Metrics And Ratios for Precigen

Frequently Asked Questions About Precigen's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools